Navigation Links
Increasing Prevalence of Heart Disease Drives Growth of Cardiac Biomarkers Diagnostics Market, Says Frost & Sullivan
Date:12/12/2012

estraint, especially for the troponin testing segment.

"The troponin testing segment, which now constitutes about a third of the cardiac marker testing market, has reached saturation," explained Sashidhar. "It is expected to grow slowly, especially in lab-based testing, with growth likely to be mainly through POC testing."

To sustain market momentum, participants need to develop customised solutions. Multi-menu options for cardiac tests and products that meet market needs, paralleled by alliances with pharmaceutical companies to develop better targeted, therapy-oriented solutions, will keep the market on a growth trajectory.

"Companies need to develop monitoring systems with sufficient product differentiation features to stay competitive," concluded Sashidhar. "Regardless of the test solution, ease-of-use and reliability will be essential to sustain growth."

If you are interested in more information on this study, please send an email with your contact details to Anna Zanchi, Corporate Communications, at anna.zanchi@frost.com

Analysis of European Cardiac Biomarkers Diagnostics Market is part of the Life Sciences Growth Partnership Service programme, which also includes research in the following markets: Western European In Vitro Diagnostics (IVD) Market, Strategic Analysis of CEE IVD Market, European Point of Care Testing Market and Global IVD Market. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities an
'/>"/>

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AssureRx Health Expands Management Team to Support Increasing Business Growth
2. Global Hospital Supplies Market to 2018 - Increasing Preference for Electro-mechanical Tables over Conventional Hydraulic Models to Drive Market Growth: MarketResearchReports.Biz
3. RMANJ Research Demonstrates That Egg Freezing Prior To IVF Yields Positive Outcomes Without Increasing Risk Of Aneuploidy
4. Patient Monitoring Devices Market in Emerging Countries (China, India, Brazil) to 2017 - Increasing Government Spending and Foreign Direct Investment (FDI) to Drive Future Growth
5. Social Norms, Life Changes and Increasing Pressures Contribute to Substance Abuse Among Adult Women
6. Increasing Minimal Invasive Surgeries to Boost Adoption of Hybrid Operating Rooms in Europe, Says Frost & Sullivan
7. Patient Monitoring Devices Market to 2017 - Increasing Use of Wireless Remote Patient Monitoring to be the Key Technology Trend
8. Cardiac Rhythm Management Devices Market to 2017 - Technological Innovations, Regulatory Approvals and Increasing Disease Prevalence Present Growth Opportunities
9. Diabetes Care Devices in Emerging Countries (China, India, Brazil) to 2017 - Greater Awareness is Increasing Demand for Self-Monitoring of Blood Glucose (SMBG) in the Home Care Segment
10. Pharma Execs Continue Looking For Growth Opportunities In Spite Of Increasing Regulatory Challenges: KPMG Survey
11. Increasing Incidence of Cardiovascular Diseases to Drive The Cardiovascular Devices Market in Emerging Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... SAN FRANCISCO , June 29, ... company,s novel blood-draw technology has received CE Mark ... quality from the European Union. This regulatory milestone ... alternative to one of the most common procedures ... Velano Vascular,s proprietary device reduces the ...
(Date:6/29/2015)... , June 29, 2015 ... and predicted revenues ,Where is the market for dermatological ... market? Visiongain ,s new report shows you potential ... and prospects. Our 310 page report ... most lucrative areas in the industry and the future ...
(Date:6/29/2015)... Calif. , June 29, 2015  The ... innovative features to cars on the basis of ... The industry is now on the verge of ... cars. While automotive HWW non-critical features such as ... be present in 30 to 40 percent of ...
Breaking Medicine Technology:Velano Vascular Receives CE Mark For Novel Blood Draw Technology Designed to Reduce Needle Exposures for Hospitalized Patients and Healthcare Providers 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 3Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 4Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 5Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 6Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 7Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 8Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 2Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 3Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 4
... Expected in November 2008, BOTHELL, Wash., Oct. 9 ... the completion of patient enrollment and dosing,for the third ... and,efficacy of its formulation of 12-hour extended-release (ER) ibuprofen ... top-line,results from this pivotal trial in November 2008. Ibuprofen ...
... Will Reduce Animal Use in Cosmetics and Chemicals ... Corp. today announced,that results of a recently completed ... EpiDerm in vitro human skin tissue,equivalent. The test ... to be accepted as a validated alternative to ...
Cached Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2
(Date:6/29/2015)... ... June 29, 2015 , ... Mediaplanet has released the ... USA TODAY. This 12-page, glossy, full-color special section hit newsstands Friday, June 26th, ... totaling approximately 450,000 copies, with an estimated readership of 1.3 million. The digital ...
(Date:6/29/2015)... ... June 29, 2015 , ... Brittenford Systems, a provider ... other growing businesses across the United States, has announced that it has been ... fifth consecutive year. , Based on company revenue and number of employees, Bob ...
(Date:6/29/2015)... , ... June 29, 2015 , ... ... developed a new approach to build nearly complete genomes by combining high-throughput DNA ... genomic variation, critically important for their association with human disease, but previously difficult ...
(Date:6/29/2015)... (PRWEB) , ... June 29, 2015 , ... San ... to lift and tighten sagging skin. Ulthera is a special treatment that offers a ... uses ultrasound technology to gently stimulate collagen production. Ulthera is highly targeted and precise ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... Biology and Chemical Technology of The Hong Kong Polytechnic University (PolyU) has developed ... oils. Authentication of edible oils has been a long-term issue in food safety, ...
Breaking Medicine News(10 mins):Health News:Mediaplanet partners with USA TODAY and Kris Letang to raise awareness about the risk of heart attack and stroke 2Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 2Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 2Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 4Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 2Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 3Health News:PolyU develops a new method for rapid authentication of edible oils and screening of gutter oils 2
... a bewildering array of regulatory DNA sequences interacting with a ... which genes are active when and where. Understanding how ... past decades but we are now starting to make significant ... how the entire complexity evolves to give differences in the ...
... giving up smoking after a programme involving sending motivational and ... months. , The findings of the txt2stop trial, which was ... and funded by the Medical Research Council, are published in ... innovative approach to the deadly problem of smoking, which is ...
... Current or heavy smokers who were screened with low-dose spiral ... deaths from lung cancer than did those who were screened ... clinical trial that involved more than 53,000 people. The ... in individuals at high risk of developing lung cancer to ...
... 29, 2011) A new treatment option may soon ... published in the July issue of The Journal ... that combined positron emission tomography and X-ray computed tomography ... refractory or relapsed high-risk neuroblastoma for treatment with a ...
... News) -- A new study reveals that 90 percent of ... started smoking, drinking or using drugs before they were 18 ... Americans who began using any addictive substance before age 18 ... using an addictive substance when they were 21 or older. ...
... cancer has provided the most comprehensive and integrated view of ... adenocarcinoma tumors from 500 patients were examined by The Cancer ... the June 30, 2011, issue of Nature . ... cancer, accounting for about 85 percent of all ovarian cancer ...
Cached Medicine News:Health News:Many a mickle makes a muckle: How changes in animals' size and shape arise 2Health News:Text message support for smokers doubles quit rates 2Health News:Screening with low-dose spiral CT scanning reduces lung cancer deaths by 20 percent 2Health News:Screening with low-dose spiral CT scanning reduces lung cancer deaths by 20 percent 3Health News:New therapy for childhood neuroblastoma proves feasible and safe 2Health News:Addiction Starts Early in American Society, Report Finds 2Health News:Addiction Starts Early in American Society, Report Finds 3Health News:The Cancer Genome Atlas completes detailed ovarian cancer analysis 2Health News:The Cancer Genome Atlas completes detailed ovarian cancer analysis 3
... A concentrated enzymatic cleanser ... semi-automated hematology instruments. It ... all Abbott CELL-DYN® hematology ... instruments. The shelf life ...
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Streck-Diluent III Plus is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 3000, 3500 and 3700. The shelf...
Streck-Diluent IIIA is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1700. The shelf life is one year f...
Medicine Products: